Bristol-based SME, Baltimore Consulting, have raised a further £1,000 for cancer charity, Cancer Research UK on World Cancer Day 2024.
On 4th February 2024, big-hearted business, Baltimore Consulting, set out to complete 150 miles in 24 hours in an effort to raise £1,000. As a collective, the team ran, walked, cycled and swam 256 miles.
We don’t do things by halves – cancer may be relentless, but so are we!
Cancer survival rates have more than doubled over the past 40 years. Consistent progress is being made, but improvements to technologies and groundbreaking work offer new opportunities for the charity to find ways to prevent, diagnose and treat cancer, and improve survival rates even further.
To help test potentially life-saving treatments and find the most promising new cancer drugs, £1,000 will prove vital in buying imaging software that CRUK scientists use to film cells in real time.
Last year, we surpassed our £40,000 fundraising milestone for Cancer Research UK (CRUK).
Charity contribution is an integral aspect of Baltimore Consulting’s business model and CRUK’s work is not only a cause that is extremely close to CEO, Charmaine Vincent’s heart, but the wider business as well.
As a business, we have seen the effects of cancer first-hand. We’ve felt the impact, and experienced the heartache caused from losing someone you love to cancer. This is what keeps us all motivated and encourages us to continually push the boundaries when it comes to fundraising.
In 2021, we were awarded Corporate Fundraising Team of the Year at CRUK’s Flame of Home Awards, having been nominated by the charity themselves in recognition of our efforts.
As our charity of choice, Baltimore Consulting have raised over £40,000 for the charity since November 2019, through undertaking several fundraising initiatives and challenges, from celebrity hosted gala dinners and auctions, to skydives and walking challenges.
Cancer Research UK’s determination to beat the disease hasn’t faltered since the onset of the Covid-19 pandemic; the charity are more focussed than ever on their ambition of seeing 3 in 4 people survive their cancer by 2034.
However, their progress relies on the incredible dedication and commitment of volunteers without whom they would not be able to fund life-saving work.
One in two of us will get cancer in our lifetime. All of us can support the research that will beat it.
